End-to-end saRNA manufacturing: Integrated development and in vivo potency

A self-amplifying RNA (saRNA) platform that is not only integrated from in vitro transcription (IVT) optimization to LNP formulation, but also scalable, cost-efficient, and GMP-compliant?
Samsung Biologics has developed a strategic, two-pronged workflow:
- an saRNA IVT platform that maximizes titer and integrity in a cost-efficient, GMP-aligned manner, and
- an LNP formulation platform that delivers mRNA/saRNA tailored to client-specific performance and targeting requirements.

A self-amplifying RNA (saRNA) platform that is not only integrated from in vitro transcription (IVT) optimization to LNP formulation, but also scalable, cost-efficient, and GMP-compliant?
Samsung Biologics has developed a strategic, two-pronged workflow:
- an saRNA IVT platform that maximizes titer and integrity in a cost-efficient, GMP-aligned manner, and
- an LNP formulation platform that delivers mRNA/saRNA tailored to client-specific performance and targeting requirements.
Related Content